AMENDMENT NO. 1 TO STEMCELLS, INC. 10,000,000 SHARES CONTROLLED EQUITY OFFERINGsm SALES AGREEMENTControlled Equity Offering Sales Agreement • July 18th, 2008 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 18th, 2008 Company Industry JurisdictionThis Amendment No. 1 to the Controlled Equity Offering Sales Agreement (the “Amendment”) entered into as of July 18, 2008 amends the Controlled Equity Offeringsm Sales Agreement (the “Agreement”) dated as of December 26, 2006 by and between STEMCELLS, INC., a Delaware corporation (the “Company”) and Cantor Fitzgerald & Co. (“Cantor”).